Immuto CEO Faraz Choudhury spoke with Pharmaceutical Executive about his company’s work with focusing on Surface Protein Conformations (SPCs) for target discovery. According to him, traditional target ...

While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...

Early cancer detection often relies on complex, invasive, and time-consuming staining procedures. A research team from Southeast University has developed a novel "label-free" biosensor that uses the ...